Cite
MLA Citation
B. Besse et al.. “16LBA Phase II, single-arm trial (BIRCH) of atezolizumab as first-line or subsequent therapy for locally advanced or metastatic PD-L1-selected non-small cell lung cancer (NSCLC).” European journal of cancer, vol. 51, n.d., pp. S717–S718. http://access.bl.uk/ark:/81055/vdc_100030687872.0x00004a